LV5794A4 - Nonapeptidi ar bombezina antagonistu ipasibam - Google Patents
Nonapeptidi ar bombezina antagonistu ipasibamInfo
- Publication number
- LV5794A4 LV5794A4 LV960305A LV960305A LV5794A4 LV 5794 A4 LV5794 A4 LV 5794A4 LV 960305 A LV960305 A LV 960305A LV 960305 A LV960305 A LV 960305A LV 5794 A4 LV5794 A4 LV 5794A4
- Authority
- LV
- Latvia
- Prior art keywords
- phenyl
- alkyl
- hydrogen
- 10alkyl
- nonapeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/619,747 US5244883A (en) | 1990-11-29 | 1990-11-29 | Nonapeptide bombesin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
LV5794A4 true LV5794A4 (lv) | 1997-02-20 |
LV5794B4 LV5794B4 (lv) | 1997-08-20 |
Family
ID=24483142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV960305A LV5794B4 (lv) | 1990-11-29 | 1996-07-22 | Nonapeptidi ar bombezina antagonistu ipasibam |
Country Status (26)
Country | Link |
---|---|
US (1) | US5244883A (lv) |
EP (1) | EP0559756B1 (lv) |
JP (1) | JPH06503090A (lv) |
KR (1) | KR100225679B1 (lv) |
AT (1) | ATE120760T1 (lv) |
AU (1) | AU657723B2 (lv) |
CA (1) | CA2097192C (lv) |
CZ (1) | CZ281533B6 (lv) |
DE (1) | DE69108738T2 (lv) |
DK (1) | DK0559756T3 (lv) |
ES (1) | ES2072137T3 (lv) |
FI (1) | FI104253B (lv) |
GR (1) | GR3015866T3 (lv) |
HU (2) | HU213114B (lv) |
IE (1) | IE62722B1 (lv) |
LV (1) | LV5794B4 (lv) |
MC (1) | MC2326A1 (lv) |
NO (1) | NO311362B1 (lv) |
NZ (1) | NZ240628A (lv) |
PL (1) | PL169498B1 (lv) |
PT (1) | PT99667B (lv) |
RU (1) | RU2115659C1 (lv) |
SK (1) | SK283541B6 (lv) |
WO (1) | WO1992009626A1 (lv) |
YU (1) | YU48751B (lv) |
ZA (1) | ZA919387B (lv) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877277A (en) * | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
WO1991004040A1 (en) * | 1989-09-15 | 1991-04-04 | Biomeasure, Inc. | Treatment of colon cancer |
US5162336A (en) * | 1990-06-21 | 1992-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists |
US5834433A (en) * | 1990-07-26 | 1998-11-10 | Merrell Pharmaceuticals Inc. | Compounds and pharmaceutical uses of peptides of bombesin and GRP |
US5369094A (en) * | 1990-11-29 | 1994-11-29 | The Administrators Of The Tulane Educational Fund | Polypeptide bombesin antagonists |
HUT71585A (en) * | 1992-02-07 | 1995-12-28 | Merrell Dow Pharma | Process for producing bombesin phenylalanine analogue peptides |
US5620955A (en) * | 1993-06-18 | 1997-04-15 | Peptide Technologies Corporation | Bombesin receptor antagonists and uses thereof |
DE4320201A1 (de) * | 1993-06-18 | 1995-01-12 | Asta Medica Ag | Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation |
US5997870A (en) * | 1994-06-03 | 1999-12-07 | Ludwig Institute For Cancer Research | Isolated peptides which bind to HLA-B44 Molecules |
US5650395A (en) * | 1995-03-13 | 1997-07-22 | Hurel; Steven | Treatment of pulmonary hypertension |
US5972895A (en) * | 1996-12-11 | 1999-10-26 | A. Glenn Braswell | Composition and method for increasing growth hormone levels |
US6200546B1 (en) | 1997-04-22 | 2001-03-13 | The Curators Of The University Of Missouri | Gastrin receptor-avid peptide conjugates |
US7922998B2 (en) * | 2003-01-13 | 2011-04-12 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
US8420050B2 (en) * | 2003-01-13 | 2013-04-16 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7850947B2 (en) | 2003-01-13 | 2010-12-14 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US20060239923A1 (en) * | 2003-01-13 | 2006-10-26 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7611692B2 (en) * | 2003-01-13 | 2009-11-03 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
JP4610345B2 (ja) * | 2003-01-13 | 2011-01-12 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 医薬品化合物のための改善されたリンカー |
US7795385B2 (en) * | 2004-12-17 | 2010-09-14 | Bexar Global, Inc. | Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
JPWO2006115135A1 (ja) * | 2005-04-21 | 2008-12-18 | アステラス製薬株式会社 | 過敏性腸症候群治療剤 |
US8557776B2 (en) | 2006-09-08 | 2013-10-15 | Bayer Pharma AG | Compounds and methods for 18F labeled agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839465A (en) * | 1987-01-20 | 1989-06-13 | Sterling Drug Inc. | Di-(D-tryptophyl and/or tetrahydropyridoindolylcarbonyl)-containing peptide amides and process for preparation thereof |
JP2795449B2 (ja) * | 1987-09-24 | 1998-09-10 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ペプチド |
GB8808768D0 (en) * | 1988-04-14 | 1988-05-18 | Erba Carlo Spa | Peptide ligands for bombesin receptors |
GR1000608B (el) * | 1988-07-21 | 1992-08-31 | Erba Carlo Spa | Μεθοδος για την παρασκευη ανταγωνιστων bombesin. |
MC2144A1 (fr) * | 1988-10-14 | 1992-02-19 | Univ Tulane | Peptides therapeutiques |
-
1990
- 1990-11-29 US US07/619,747 patent/US5244883A/en not_active Expired - Lifetime
-
1991
- 1991-11-15 WO PCT/US1991/008534 patent/WO1992009626A1/en active IP Right Grant
- 1991-11-15 MC MC912326D patent/MC2326A1/xx unknown
- 1991-11-15 SK SK551-93A patent/SK283541B6/sk unknown
- 1991-11-15 EP EP92900740A patent/EP0559756B1/en not_active Expired - Lifetime
- 1991-11-15 CZ CS931006A patent/CZ281533B6/cs not_active IP Right Cessation
- 1991-11-15 DE DE69108738T patent/DE69108738T2/de not_active Expired - Fee Related
- 1991-11-15 KR KR1019930701620A patent/KR100225679B1/ko not_active IP Right Cessation
- 1991-11-15 RU RU93041053A patent/RU2115659C1/ru not_active IP Right Cessation
- 1991-11-15 AT AT92900740T patent/ATE120760T1/de not_active IP Right Cessation
- 1991-11-15 CA CA002097192A patent/CA2097192C/en not_active Expired - Fee Related
- 1991-11-15 ES ES92900740T patent/ES2072137T3/es not_active Expired - Lifetime
- 1991-11-15 JP JP4501946A patent/JPH06503090A/ja active Granted
- 1991-11-15 DK DK92900740.9T patent/DK0559756T3/da active
- 1991-11-15 HU HU9301567A patent/HU213114B/hu unknown
- 1991-11-15 PL PL91300477A patent/PL169498B1/pl not_active IP Right Cessation
- 1991-11-15 AU AU90645/91A patent/AU657723B2/en not_active Ceased
- 1991-11-18 NZ NZ24062891A patent/NZ240628A/en not_active IP Right Cessation
- 1991-11-22 YU YU183491A patent/YU48751B/sh unknown
- 1991-11-28 IE IE414091A patent/IE62722B1/en not_active IP Right Cessation
- 1991-11-28 ZA ZA919387A patent/ZA919387B/xx unknown
- 1991-11-29 PT PT99667A patent/PT99667B/pt not_active IP Right Cessation
-
1993
- 1993-05-28 FI FI932457A patent/FI104253B/fi not_active IP Right Cessation
- 1993-05-28 NO NO19931977A patent/NO311362B1/no unknown
-
1995
- 1995-04-19 GR GR950400995T patent/GR3015866T3/el unknown
- 1995-06-27 HU HU95P/P00466P patent/HU211603A9/hu unknown
-
1996
- 1996-07-22 LV LV960305A patent/LV5794B4/lv unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV5794A4 (lv) | Nonapeptidi ar bombezina antagonistu ipasibam | |
SE9604341D0 (sv) | Hepta-peptide oxytocin analogue | |
UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
ES2137998T3 (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
ES8105698A1 (es) | Procedimiento para la obtencion de octapeptidos ciclicos | |
DK1086124T3 (da) | Nye cyclosporiner | |
CY1111740T1 (el) | Συζευγματα πεπτιδιων ν- και/ή c-τελικως τροποποιημενα μεσω βραχεων αλυσων φορτισμενων πεπτιδιων | |
DK0973801T3 (da) | GnRH-antagonister | |
JPH01113353A (ja) | 抗高血圧剤としてのα−アミノアシルβ−アミノアシルアミノジオール | |
NO944293L (no) | Bombesin antagonist-polypeptider | |
CY1107990T1 (el) | Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων | |
ATE10836T1 (de) | Peptide und ihre anwendung in der therapeutik. | |
ES2135695T3 (es) | Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2. | |
GB927714A (en) | New cyclic octapeptides | |
AR002715A1 (es) | Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados | |
HU181402B (en) | Process for preparing new peptides with psychopharmacological activity | |
NO931091L (no) | Analoger av sykloinopeptid a og anvendelse derav |